BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7030902)

  • 1. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
    Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A
    Hepatology; 1981; 1(5):377-85. PubMed ID: 7030902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial.
    Coutinho RA; Lelie N; Albrecht-Van Lent P; Reerink-Brongers EE; Stoutjesdijk L; Dees P; Nivard J; Huisman J; Reesink HW
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1305-8. PubMed ID: 6404440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.
    Francis DP; Hadler SC; Thompson SE; Maynard JE; Ostrow DG; Altman N; Braff EH; O'Malley P; Hawkins D; Judson FN; Penley K; Nylund T; Christie G; Meyers F; Moore JN; Gardner A; Doto IL; Miller JH; Reynolds GH; Murphy BL; Schable CA; Clark BT; Curran JW; Redeker AG
    Ann Intern Med; 1982 Sep; 97(3):362-6. PubMed ID: 6810736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
    N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Alter HJ; Taylor PE; DeVera A; Chen GT; Kellner A
    N Engl J Med; 1982 Dec; 307(24):1481-6. PubMed ID: 6755247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
    Dienstag JL; Werner BG; Polk BF; Snydman DR; Craven DE; Platt R; Crumpacker CS; Ouellet-Hellstrom R; Grady GF
    Ann Intern Med; 1984 Jul; 101(1):34-40. PubMed ID: 6233921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
    Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial.
    Desmyter J; Colaert J; De Groote G; Reynders M; Reerink-Brongers EE; Lelie PN; Dees PJ; Reesink HW
    Lancet; 1983 Dec; 2(8363):1323-8. PubMed ID: 6139668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
    Stevens CE; Alter HJ; Taylor PE; Zang EA; Harley EJ; Szmuness W
    N Engl J Med; 1984 Aug; 311(8):496-501. PubMed ID: 6235453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine.
    Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC
    Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols.
    Szmuness W
    J Med Virol; 1979; 4(4):327-40. PubMed ID: 541683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands.
    Coutinho RA; Lelie PN; Albrecht-van Lent P; Stoutjesdijk L; Huisman J; Kuipers H; Schut LJ; Reerink-Brongers EE; Reesink HW; van Aken WG
    Dev Biol Stand; 1983; 54():287-92. PubMed ID: 6228469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
    Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
    N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal).
    Maupas P; Chiron JP; Barin F; Coursaget P; Goudeau A; Perrin J; Denis F; Mar ID
    Lancet; 1981 Feb; 1(8215):289-92. PubMed ID: 6109938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.
    Xu ZY; Liu CB; Francis DP; Purcell RH; Gun ZL; Duan SC; Chen RJ; Margolis HS; Huang CH; Maynard JE
    Pediatrics; 1985 Nov; 76(5):713-8. PubMed ID: 3903646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and chimpanzee testing of a vaccine against human hepatitis B.
    Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hilleman MR
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):694-700. PubMed ID: 817293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.
    Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
    Lancet; 1981 Apr; 1(8224):797-800. PubMed ID: 6111671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.